Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04155593 · ClinicalTrials.gov registry record
In-office Assessment of Voiding Function Following Botox Injection for Overactive Bladder
A clinical trial, sponsored by TriHealth.
- Completed
- Registry status
- 135
- Enrollment target
NCT04155593 is a clinical trial that has completed, run by TriHealth. The registered enrollment target is 135 participants.
The verdict
NCT04155593 has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- 135 participants
- Enrollment target
Study Summary
The purpose of this study is to describe the rates of elevated post void residual (PVR) (defined as \>200mL) in Cincinnati Urogynecology Associates patients following Botox injection, as well as to document how many patients required treatment with clean intermittent self-catheterization (CISC).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2019-11-08 |
| Est. Completion | 2020-07-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04155593
The ClinicalTrials.gov registry entry for NCT04155593 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04155593 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04155593 about?
NCT04155593 is a clinical study titled "In-office Assessment of Voiding Function Following Botox Injection for Overactive Bladder". The purpose of this study is to describe the rates of elevated post void residual (PVR) (defined as \>200mL) in Cincinnati Urogynecology Associates patients following Botox injection, as well as to document how many patients required treatment with clean intermittent self-catheterization (CISC).
What is the current status of trial NCT04155593?
This trial is currently completed. The enrollment target is 135 participants. The study started on 2019-11-08. Estimated completion is 2020-07-15.
Who is sponsoring clinical trial NCT04155593?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.